全文获取类型
收费全文 | 69479篇 |
免费 | 4854篇 |
国内免费 | 2475篇 |
专业分类
耳鼻咽喉 | 314篇 |
儿科学 | 931篇 |
妇产科学 | 1003篇 |
基础医学 | 12028篇 |
口腔科学 | 946篇 |
临床医学 | 3715篇 |
内科学 | 10739篇 |
皮肤病学 | 1047篇 |
神经病学 | 10730篇 |
特种医学 | 819篇 |
外国民族医学 | 19篇 |
外科学 | 4094篇 |
综合类 | 7419篇 |
现状与发展 | 7篇 |
预防医学 | 1587篇 |
眼科学 | 604篇 |
药学 | 13348篇 |
5篇 | |
中国医学 | 1430篇 |
肿瘤学 | 6023篇 |
出版年
2024年 | 85篇 |
2023年 | 756篇 |
2022年 | 1209篇 |
2021年 | 2016篇 |
2020年 | 1738篇 |
2019年 | 1770篇 |
2018年 | 1859篇 |
2017年 | 1872篇 |
2016年 | 1955篇 |
2015年 | 2284篇 |
2014年 | 3754篇 |
2013年 | 5018篇 |
2012年 | 3737篇 |
2011年 | 4363篇 |
2010年 | 3617篇 |
2009年 | 3701篇 |
2008年 | 4020篇 |
2007年 | 3637篇 |
2006年 | 3164篇 |
2005年 | 2731篇 |
2004年 | 2565篇 |
2003年 | 2373篇 |
2002年 | 1903篇 |
2001年 | 1668篇 |
2000年 | 1522篇 |
1999年 | 1353篇 |
1998年 | 1516篇 |
1997年 | 1413篇 |
1996年 | 1292篇 |
1995年 | 1037篇 |
1994年 | 948篇 |
1993年 | 852篇 |
1992年 | 664篇 |
1991年 | 615篇 |
1990年 | 453篇 |
1989年 | 400篇 |
1988年 | 350篇 |
1987年 | 322篇 |
1986年 | 327篇 |
1985年 | 371篇 |
1984年 | 314篇 |
1983年 | 197篇 |
1982年 | 269篇 |
1981年 | 209篇 |
1980年 | 154篇 |
1979年 | 102篇 |
1978年 | 75篇 |
1977年 | 62篇 |
1976年 | 51篇 |
1975年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system 总被引:4,自引:0,他引:4
The insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor is a multifunctional single transmembrane glycoprotein which, along with the cation-dependent M6P (CD-M6P) receptor, mediates the trafficking of M6P-containing lysosomal enzymes from the trans-Golgi network (TGN) to lysosomes. Cell surface IGF-II/M6P receptors also function in the degradation of the non-glycosylated IGF-II polypeptide hormone, as well as in the capture and activation/degradation of extracellular M6P-bearing ligands. In recent years, the multifaceted role of the receptor has become apparent, as several lines of evidence have indicated that in addition to its role in lysosomal enzyme trafficking, clearance and/or activation of a variety of growth factors and endocytosis-mediated degradation of IGF-II, the IGF-II/M6P receptor may also mediate transmembrane signal transduction in response to IGF-II binding under certain conditions. However, very little is known about the physiological significance of the receptor in the function of the central nervous system (CNS). This review aims to delineate what is currently known about IGF-II/M6P receptor structure, its ligand binding properties and role in lysosomal enzyme transport. It also summarizes the recent data regarding the role of the receptor in the CNS, including its distribution, possible importance for normal and activity-dependent functioning as well as its implications in neurodegenerative disorders such as Alzheimer's disease (AD). 相似文献
132.
The seven serotypes (A–G) of botulinum neurotoxin (BoNT) are proteins produced by Clostridium botulinum and have multifunctional abilities: (i) they target cholinergic nerve endings via binding to ecto‐acceptors (ii) they undergo endocytosis/translocation and (iii) their light chains act intraneuronally to block acetylcholine release. The fundamental process of quantal transmitter release occurs by Ca2+‐regulated exocytosis involving sensitive factor attachment protein‐25 (SNAP‐25), syntaxin and synaptobrevin. Proteolytic cleavage by BoNT‐A of nine amino acids from the C‐terminal of SNAP‐25 disables its function, causing prolonged muscle weakness. This unique combination of activities underlies the effectiveness of BoNT‐A haemagglutinin complex in treating human conditions resulting from hyperactivity at peripheral cholinergic nerve endings. In vivo imaging and immunomicroscopy of murine muscles injected with type A toxin revealed that the extended duration of action results from the longevity of its protease, persistence of the cleaved SNAP‐25 and a protracted time course for the remodelling of treated nerve–muscle synapses. In addition, an application in pain management has been indicated by the ability of BoNT to inhibit neuropeptide release from nociceptors, thereby blocking central and peripheral pain sensitization processes. The widespread cellular distribution of SNAP‐25 and the diversity of the toxin's neuronal acceptors are being exploited for other therapeutic applications. 相似文献
133.
Masao Akagi Shunji Nishimura Kohji Yoshida Takumi Kakinuma Tatsuya Sawamura Hiroshi Munakata Chiaki Hamanishi 《Journal of orthopaedic research》2006,24(8):1782-1790
Mechanical stimulation is known to be an essential factor in the regulation of cartilage metabolism. We tested the hypothesis that expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) can be modulated by cyclic tensile stretch load in chondrocytes. Cyclic loading of repeated stretch stress at 10 cycles per minute with 10 kPa of stress for 6 h induced expression of LOX-1 to 2.6 times control in cultured bovine articular chondrocytes, equivalent to the addition of 10 microg/mL oxidized low density lipoprotein (ox-LDL) (2.4 times control). Application of the cyclic load to the chondrocytes along with 10 microg/mL ox-LDL resulted in synergistically increased LOX-1 expression to 6.3 times control. Individual application of cyclic loading and 10 microg/mL ox-LDL significantly suppressed chondrocytes viability (84.6% +/- 3.4% and 80.9% +/- 3.2% of control at 24 h, respectively; n = 3; p < 0.05) and proteoglycan synthesis [81.0% +/- 7.1% and 85.7% +/- 5.2% of control at 24 h, respectively; p < 0.05 when compared with 94.6% +/- 4.6% for native-LDL (n = 3)]. Cyclic loading and 10 microg/mL ox-LDL synergistically affected cell viability and proteoglycan synthesis, which were significantly suppressed to 45.6% +/- 4.9% and 48.7% +/- 6.7% of control at 24 h, respectively (n = 3; p < 0.01 when compared with individual application of cyclic loading or 10 microg/mL ox-LDL). In this study, we demonstrated synergistic effects of cyclic tensile stretch load and ox-LDL on cell viability and proteoglycan synthesis in chondrocytes, which may be mediated through enhanced expression of LOX-1 and which has important implications in the progression of cartilage degeneration in osteoarthritis. 相似文献
134.
目的 研究在IL 2和IL 4作用下 ,趋化性细胞因子受体CCR3在人生发中心 (germinalcenter,GC)B细胞上的表达及其功能特性。方法 采用流式细胞术检测人GCB细胞上CCR3表达和在CCR3配体eotaxin作用下B细胞的凋亡 ,实时定量RT PCR和Northernblot法检测GCB细胞内CCR3mRNA的表达 ,淋巴细胞趋化和黏附试验检测B细胞的趋化和黏附能力。结果 人GCB细胞极低表达趋化性细胞因子受体CCR3,经IL 2和IL 4作用后 ,GCB细胞高表达CCR3,但此时CCR3不能在其配体作用下诱导GCB细胞的趋化和黏附功能 ,而是诱导GCB细胞凋亡。结论 IL 2和IL 4联合诱导人GCB细胞CCR3表达 ,CCR3可能具有死亡受体的功能。 相似文献
135.
136.
XGD-1对人外周血T淋巴细胞增殖和IL-2R表达的影响 总被引:1,自引:1,他引:0
目的 探讨XGD—l的免疫抑制作用及其作用机理。方法 不同浓度的XGD—l作用于植物血凝索(PHA)和刀豆索A(ConA)诱导的正常人外周血T淋巴细胞,共同培养48h和72h,用改良MTT法观察XGD—l对人T淋巴细胞增殖的影响,用流式细胞术检测XGD—l对T淋巴细胞表面IL—2R表达的影响;同时观察联合应用CsA和XGD—l对细胞增殖及IL—2R表达的影响。结果 XGD—l对PHA和ConA诱导的正常人外周血T淋巴细胞增殖有明显的抑制作用,其作用与药物浓度有关,在一定剂量范围内,抑制作用随XGD—l剂量的递增而加强;XGD—l对PHA和ConA激活的T淋巴细胞表面IL-2R的表达有显著抑制作用,阳性率从正常对照活化细胞的47.67%降为25.03%;联合应用CsA,上述抑制作用增强。结论 XGD-l具有免疫抑制作用,能降低IL-2R表达,可能是其免疫抑制作用的重要机理之一。 相似文献
137.
中国人HNPCC家系的临床特征及M3胆碱能受体基因(A)8区突变检测 总被引:1,自引:1,他引:0
目的:分析中国人遗传性非息肉病性大肠癌(HNPCC)家系的临床特征并检测这些家系中M3胆碱能受体基因(A)8区的突变情况.方法:根据2003年4月杭州会议制定的中国人HNPCC家系标准收集HNPCC家系共15个,分析其临床特征;提取先证者的外周血基因组DNA,PCR扩增M3胆碱能受体基因第8外显子中一段长153 bp,包含有微卫星位点(A)8的基因片段,直接进行DNA测序.结果:15个家系共有恶性肿瘤患者55例,其中大肠癌患者41例,平均每个家系发生大肠癌2.73例,73%的大肠癌患者发病年龄<50岁,51%的病灶位于近端结肠,40%发生在直肠肛门,同时和异时多原发大肠癌总发生率为12%,2/3的家系属于Lynch Ⅱ型,共发生肠外恶性肿瘤14例(18个),其中胃癌最常见.15例先证者外周血中无1例检测到M3胆碱能受体基因(A)8区的突变.结论:M3胆碱能受体基因与中国人群中HPNCC的发病可能无密切关系.中国人HNPCC家系标准应在临床工作中推广应用,并进一步验证其合理性和科学性. 相似文献
138.
前列腺癌组织中性激素受体表达的分析 总被引:3,自引:0,他引:3
目的:定性分析雄激素受体(AR)、雌激素受体(ER)、孕激素受体(PR)在良性前列腺增生(BPH)和前列腺癌(PCa)组织中的阳性表达,为激素治疗PCa和预后判断提供一定的依据。方法:采用免疫组化DAKO Envision二步法,分析30例BPH与32例PCa标本中AR、ER、PR的阳性表达情况。结果:AR、ER、PR阳性数BPH组分别为22、10、6例;PCa组分别为18、14、2例,两组差异无显著性。随访30例PCa患者术后的生存期表明:AR表达阳性者平均生存时间为6.41年,AR阴性者为4.28年,两者差异有统计学意义(P<0.05)。结论:BPH和PCa患者在性激素受体表达上的差异无显著意义;PCa患者中AR表达阳性者平均生存时间长于AR阴性者,后者的预后较差,对AR阴性者行激素治疗效果不确定。 相似文献
139.
The effects of calcium on parathyroid hormone (PTH) has further discovered in recent years. It has been known that calcium ion concentration in the extracellular fluid is a major determinant of PTH secretion. The relationship between serum intact PTH (iPTH) and calcium ion levels is described by a sigmoidal curve. The calcium concentration that produces half-maximal change in PTH release (the midpoint between maximal and minimal 相似文献
140.